Long-term blood pressure telemetry in AT2 receptor-disrupted mice

Journal of Hypertension

Volumn 18, Issue 7, 2000, Pages 955-961

  Gross, Volkmar ^c   Milia, Anna Franca ^c   Plehm, Ralph ^c   Inagami, Tadashi ^a   Luft, Friedrich C ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b Franz Vofhard Clinic   (Germany)

^c NONE

Author keywords

AT2 receptor; Circadian blood pressure; Circadian heart rate rhythm; Dietary sodium load; DOCA salt; Mouse; Telemetry

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; DEOXYCORTICOSTERONE ACETATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; AORTA PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DEVICE; HEART RATE; HYPERTENSION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALT INTAKE; TELEMETRY;

EID: 0033927087     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018070-00018     Document Type: Article

References (30)

1. 1 Siragy HM, Senbonmatsu T, Ichiki T, Inagami T, Carey RM. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 1999; 104:181-188.
2. 2 Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, et al. Effects of blood pressure and exploratory behaviour in mice lacking the angiotensin II type-2 receptor. Nature 1995; 377:748-750.
3. 3 Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995; 377:744-747.
4. 2) angiotensin receptor. Proc Natl Acad Sci USA 1999; 96:6505-6510.
5. 5 Higashi Y, Oshima T, Ozono R, Nakano Y, Matsuura T, Kambe M, et al. Nocturnal decline in blood pressure is attenuated by NaCl loading in salt-sensitive patients with essential hypertension: noninvasive 24-hour ambulatory blood pressure monitoring. Hypertension 1997; 30:163-167.
6. 6 Uzu T, Kazembe FS, Ishikawa K, Nakamura S, Inenaga T, Kimura G. High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension 1996; 28:139-142.
7. 7 Lemmer B, Mattes A, Böhm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 1993; 22:97-101.
8. 8 Pons M, Schnecko A, Witte K, Lemmer B, Waterhouse JM, Cambar J. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls. Am J Physiol 1996; 271:R1002-R1008.
9. 9 Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, et al. 'Non-dipper' hypertensive patients and progressive renal insufficiency: a 3 year longitudinal study. Clin Nephrol 1995; 43:382-387.
10. 10 Kuwajima I, Suzuki Y, Simosava T, Kanemaru A, Hoshino S, Kuramoto K. Diminished nocturnal decline in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 1992; 67:1307-1311.
11. 2 receptor. Kidney Int 2000; 57:191-202.
12. 12 Gross V, Lippoldt A, Luft FC. Pressure diuresis and natriuresis in DOCA-salt mice. Kidney Int 1997; 52:1364-1368.
13. 13 Johansson C, Thoren P. The effects of triiodothyronine (T3) on heart rate, temperature and ECG measured with telemetry in freely moving mice. Acta Physiol Scand 1997; 160:133-138.
14. 2 receptors. Hypertension 1997; 29:483-487.
15. 15 Mattson DL, Krauski KR. Chronic sodium balance and blood pressure responses to captopril in conscious mice. Hypertension 1998; 32:923-938.
16. 16 Gross V, Lippoldt A, Bohlender J, Bader M, Hansson A, Luft FC. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice. J Am Soc Nephrol 1998; 9:346-354.
17. 17 Mattes A, Witte K, Hohmann W, Lemmer B. PHARMFTT: a non-linear fitting program for pharmacology. Chronobiol Int 1991; 8:460-476.
18. 18 Okuyama S, Sakawa T, Chaki S, Imagawa Y, Ichiki T, Inagami T. Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 1999; 821:150-159.
19. 2 knockout mice. Biochem Biophys Res Commun 1999; 258:194-198.
20. 20 Seino M, Abe K, Nushiro N, Omata K, Kasai Y, Tsunoda K, et al. Role of bradykinin of blood pressure and renal blood flow in DOCA-salt hypertensive rats. J Hypertens 1990; 8:411-416.
21. 21 Naitoh M, Suzuki H, Arakawa K, Marsumoto A, Ichihara A, Marsuda H, et al. Role of kinin and renal Ang II blockade in acute effects of ACE inhibitors in low-renin hypertension. Am J Physiol 1997; 272:H679-H687.
22. 22 Lippoldt A, Gross V, Schneider K, Hannson A, Nadaud S, Schneider W, et al. Nitric oxide synthetase and renin angiotensin system gene expression in salt-sensitive and salt-resistant Sabra rats. Hypertension 1997; 30:409-415.
23. 23 Soltis EE, Field FP. Sodium pump activity and norepinephrine responsiveness of femoral arterial smooth muscle from DOCA-salt rats. Pharmacology 1987; 34:104-110.
24. 24 Jones AW, Hart RG. Altered ion transport in aortic smooth muscle during deoxycorticonsterone acetate hypertension in the rat. Circ Res 1975; 37:333-341.
25. 25 Vial JH, Young AC, Boyd GW. Onset and offset of structural arteriolar changes in DOCA/salt hypertension in the rat. Clin Exp Pharmacol Physiol 1982; 9:309-313.
26. 26 Li P, Sur SH, Mistlberger RE, Morris M. Circadian blood pressure and heart rate rhythm in mice. Am J Physiol 1999; 276:R500-R504.
27. 27 Mattes A, Lemmer B. Effects of amlodipine on circadian rhythms in blood pressure, heart rate, and motility: a telemetric study in rats. Chronobiol Int 1991; 8:526-538.
28. 28 Henry R, Casto R, Printz MP. Diurnal cardiovascular patterns in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 1990; 16:422-428.
29. 29 Wallace ECH, Balmoforth AJ, Morton JJ. Enhanced diurnal variation of blood pressure in the renal hypertensive rat: effect of angiotensin II suppression. Clin Sci 1987; 73:271-275
30. 30 Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F, Carretero OA. Endothelial nitric oxide gene knockout mice. Cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/ reperfusion injury. Hypertension 1999; 34:24-30.